
-
2003
Company Description
Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles
Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles against hepatitis C. The company was founded in 2003 and is based in Paris, France.
-
Manufacturer:
Science and Engineering -
Formed:
2003 -
Company Website:
-
Company E-mail:
-
Company Address:
5, rue des WallonsParisFrance -
CEO:
- Charlotte Dalba
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits